Prime
Treatments
Testing and Advancements Index
The Prime Treatments, Testing and Advancements Index is designed to track both event-driven news and long-term trends of companies engaged in developing treatments and vaccines, or diagnostic technology, in the fight against infectious diseases.
FACT SHEET
Prime Treatments, Testing and Advancements Primer
PDF
Infectious Diseases: Prime Treatments, Testing and Advancements Overview
PDF
Prime Treatments, Testing and Advancements Index Methodology Guide
PDF
Prime Treatments, Testing and Advancements Factsheet
PDF
Prime Treatments, Testing and Advancements Index
VIDEO
INDEX KEY FACTS
Base Date: December 12, 2019
Total number of holdings:
52
Launch date: June 08, 2020
Reconstitution: Quarterly (March, June, September and December)
Index calculation agent: Solactive AG
Weighting scheme: Modified Market Capitalization
INDEX SYMBOLS
| Version | Bloomberg | Reuters | ISIN |
|---|---|---|---|
| Prime Treatments, Testing and Advancements Index GTR | PGERM | .PGERMG | DE000SL0A030 |
| Prime Treatments, Testing and Advancements Index NTR | N/A | .PGERMN | DE000SL0A022 |
| Prime Treatments, Testing and Advancements Index PR | N/A | .PGERMP | DE000SL0A014 |
INDEX COMPOSITION
| Component Name | Ticker | Weight |
|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | ALNY | 10.37% |
| LABCORP HOLDINGS INC | LH | 7.08% |
| QUEST DIAGNOSTICS INC | DGX | 6.72% |
| VAXCYTE INC | PCVX | 6.43% |
| BIONTECH SE | BNTX | 5.54% |
| BIO-RAD LABORATORIES INC | BIO | 4.77% |
| ZAI LAB LTD | ZLAB | 4.37% |
| QUIDELORTHO CORPORATION | QDEL | 4.27% |
| BIOCRYST PHARMACEUTICALS INC | BCRX | 3.85% |
| DYNAVAX TECHNOLOGIES CORP | DVAX | 3.37% |
| IMMUNOCORE HOLDINGS PLC | IMCR | 3.27% |
| MODERNA INC | MRNA | 2.95% |
| OPKO HEALTH INC | OPK | 2.54% |
| NOVAVAX INC | NVAX | 2.49% |
| VIR BIOTECHNOLOGY INC | VIR | 2.47% |
| IMMUNITYBIO INC | IBRX | 2.32% |
| ARBUTUS BIOPHARMA CORP | ABUS | 2.01% |
| FULGENT GENETICS INC | FLGT | 1.50% |
| ADAPTIVE BIOTECHNOLOGIES CORP | ADPT | 1.47% |
| CUREVAC BV | CVAC | 1.44% |
| SIGA TECHNOLOGIES INC | SIGA | 1.28% |
| ARCTURUS THERAPEUTICS HOLDINGS INC | ARCT | 1.18% |
| GILEAD SCIENCES INC | GILD | 1.07% |
| SANOFI-ADR | SNY | 1.02% |
| ABBVIE INC | ABBV | 1.00% |
| REGENERON PHARMACEUTICALS | REGN | 0.98% |
| JOHNSON & JOHNSON | JNJ | 0.98% |
| ABBOTT LABORATORIES | ABT | 0.95% |
| TAKEDA PHARM-ADR | TAK | 0.95% |
| ELI LILLY & CO | LLY | 0.94% |
| EMERGENT BIOSOLUTIONS INC | EBS | 0.92% |
| GSK PLC-SPON ADR | GSK | 0.92% |
| ASTRAZENECA PLC-SPONS ADR | AZN | 0.89% |
| PFIZER INC | PFE | 0.86% |
| MERCK & CO. INC. | MRK | 0.79% |
| CORMEDIX INC | CRMD | 0.74% |
| ATEA PHARMACEUTICALS INC | AVIR | 0.71% |
| ORASURE TECHNOLOGIES INC | OSUR | 0.71% |
| OCUGEN INC | OCGN | 0.69% |
| ENANTA PHARMACEUTICALS INC | ENTA | 0.57% |
| XBIOTECH INC | XBIT | 0.46% |
| INOVIO PHARMACEUTICALS INC | INO | 0.38% |
| VAXART INC | VXRT | 0.37% |
| INVIVYD INC | IVVD | 0.23% |
| RENOVARO BIOSCIENCES INC | RENB | 0.21% |
| INFLARX NV | IFRX | 0.21% |
| HILLEVAX INC | HLVX | 0.20% |
| CHIMERIX INC | CMRX | 0.18% |
| CEL-SCI CORP | CVM | 0.14% |
| GRITSTONE BIO INC | GRTS | 0.12% |
| CUE BIOPHARMA INC | CUE | 0.07% |
| AN2 THERAPEUTICS INC | ANTX | 0.07% |